Clinical Trial Update: Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody [Phase 2]

View source ↗

Summary

A Phase 2 pediatric trial is recruiting presymptomatic Stage 1 Type 1 diabetes patients to test a regulatory T cell therapy in combination with an anti-CD20 ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Anti-CD20 monoclonal antibody
• Treg cell preparation (regulatory T cell therapy)

Snippet

Sponsor: PolTREG S.A. | Conditions: Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I | Phase 2 | Status: RECRUITING